Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases
Clinical data show that 3050% of adults may experience telogen effluvium following significant physiologic stress, including rapid weight loss
You may not even know exactly what youre getting or whether the dose is accurate from one administration to the next. Indeed, GLP-1 use without medical oversight heightens the risk of medication side effects, such as gallbladder disease, pancreatitis, thyroid conditions, retinopathy and nutrient deficiencies
If your Mounjaro dose is unavailable and the shortage timeline is uncertain, switching to Ozempic keeps you on active GLP-1 treatment rather than going without
This form will determine if they are eligible for GLP-1 medication
The paucity of data prevents us from concluding that there is a possible increase in the fracture risk following calorie restriction